As of January 2025, Seoulin Bioscience has a market cap of $36.59M. This makes Seoulin Bioscience the world's 24893th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $47.46M | 3.04% |
2023 | $46.05M | -19.14% |
2022 | $56.96M | -44.10% |
2021 | $101.89M | 62.71% |
2020 | $62.62M | 58.26% |
2019 | $39.57M | -8.77% |
2018 | $43.37M | -6.40% |
2017 | $46.34M | -18.25% |
2016 | $56.68M | 2.99% |
2015 | $55.03M | 97.34% |
2014 | $27.89M | -15.89% |
2013 | $33.16M | -17.32% |
2012 | $40.10M | - |